An interdisciplinary debate initiated by the European Society Of Cardiology Working Group on valvular heart disease

EuroIntervention

Volumn 7, Issue 11, 2012, Pages 1257-1274

  Naber, Christoph K ^a   Prendergast, Bernard ^b   Thomas, Martyn ^c   Vahanian, Alec ^d   Iung, Bernard ^d   Rosenhek, Raphael ^e   Tornos, Pilar ^f   Otto, Catherine M ^g   Antunes, Manuel J ^h   Kappetein, Pieter ⁱ   Lange, Ruediger ^j   Wendler, Olaf ^k  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d BICHAT HOSPITAL   (France)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF COIMBRA   (Portugal)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTERY CALCIFICATION; ARTIFICIAL HEART PACEMAKER; CARDIOPULMONARY BYPASS; CATHETERIZATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; ECHOCARDIOGRAPHY; FOLLOW UP; FRAIL ELDERLY; HEART HEMODYNAMICS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; LIFE EXPECTANCY; MEDICAL SOCIETY; MEDICAL SPECIALIST; NOTE; NUTRITIONAL STATUS; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; POSTOPERATIVE CARE; PROGNOSIS; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOGENICITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULAR HEART DISEASE;

ADULT; AORTIC VALVE STENOSIS; CARDIOLOGY; EUROPE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; RISK FACTORS;

EID: 84859095550     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I11A201     Document Type: Note

References (62)

1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607
2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
3. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-90.
4. Buellesfeld L, Gerckens U, Schuler G, Bonan R, Kovac J, Serruys PW, Labinaz M, den Heijer P, Mullen M, Tymchak W, Windecker S, Mueller R, Grube E. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol. 2011;57:1650-7.
5. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006;295:801-808. (Pubitemid 43244307)
6. Buellesfeld L, Wenaweser P, Gerckens U, Mueller R, Sauren B, Latsios G, Zickmann B, Hellige G, Windecker S, Grube E. Transcatheter aortic valve implantation: predictors of procedural success--the Siegburg-Bern experience. Eur Heart J. 2010; 31:984-991.
7. Himbert D, Descoutures F, Al-Attar N, Iung B, Ducrocq G, Detaint D, Brochet E, Messika-Zeitoun D, Francis F, Ibrahim H, Nataf P, Vahanian A. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol. 2009;54:303-311.
8. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention. 2008;4:193-199.
9. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-197.
10. Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A, Webb JG. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation. 2010;122:1319-1327.
11. Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, Masson JB, Gutierrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodes-Cabau J. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31:865-874.
12. Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H, Eggebrecht H, Senges J, Richardt G. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899-906.
13. Rodes-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bedard F, Doyle D, De Larochelliere R, Jayasuria C, Villeneuve J, Marrero A, Cote M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18-28.
14. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425-433.
15. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr. 2009;10:1-25.
16. Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, Kappetein AP, Stepinska J, Kaden JJ, Naber CK, Acarturk E, Gohlke-Barwolf C. ESC Working Group onValvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J. 2011. March 15 [Epub ahead of print]
17. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J, Spyt T, Maccarthy PA, Wendler O, Hildick-Smith D, Davies SW, Trivedi U, Blackman DJ, Levy RD, Brecker SJ, Baumbach A, Daniel T, Gray H, Mullen MJ. Long-Term Outcomes After Transcatheter Aortic Valve Implantation in High-Risk Patients With Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58: 2130-2138.
18. Amat-Santos I, Rodés-Cabau J, Urena M, Delarochellière R, Doyle D, Bagur R, Villeneuve J, MD, Côté M,Nombela-Franco L, Philippon F, Pibarot P, Dumont E. Incidence, predictive factors and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59; 178-188
19. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57: 253-269.
20. Jilaihawi H, Bonan R, Asgar A, Ibrahim R, Spyt T, Chin D, Kovac J. Anatomic suitability for present and next generation transcatheter aortic valve prostheses: evidence for a complementary multidevice approach to treatment. JACC Cardiovasc Interv. 2010; 3:859-866.
21. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8:162-172.
22. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
23. Holmes DR, Mack MJ. Transcatheter valve therapy: a professional society overview from the American college of cardiology foundation and the society of thoracic surgeons. Ann Thorac Surg. 2011;92:380-9.
24. Brown JM, O'Brien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108, 687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thoracic Cardiovasc Surg. 2009;137:82-90
25. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2008;135:180-7.
26. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-9.
27. Zamorano JL, Badano LP, Bruce C, Chan KL, Gonçalves A, Hahn RT, Keane MG, La Canna G, Monaghan MJ, Nihoyannopoulos P, Silvestry FE, Vanoverschelde JL, Gillam LD, Vahanian A, Di Bello V, Buck T. EAA/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur J Echocardiogr. 2011;12: 557-584.
28. Schultz CJ, Moelker AD, Tzikas A, Rossi A, van Geuns RJ, de Feyter PJ, Serruys PW. Cardiac CT: necessary for precise sizing for transcatheter aortic implantation. EuroIntervention. 2010;6 SupplG:G6-G13.
29. Sherif MA, Abdel-Wahab M, Stöcker B, Geist V, Richardt D, Tölg R, Richardt G. Anatomic and procedural predictors of paraval vular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010;56:1623-9.
30. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder AJ, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali SS, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde JC, Hildick-Smith D. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation. 2011;123:951-60.
31. Takeda K, Matsumiya G, Sakaguchi T, Miyagawa S, Yamauchi T, Shudo Y, Izutani H, Sawa Y. Impact of untreated mild-to-moderate mitral regurgitation at the time of isolated aortic valve replacement on late adverse outcomes. Eur J Cardiothorac Surg. 2010;37:1033-8.
32. Hekimian G, Detaint D, Messika-Zeitoun D, Attias D, Iung B, Himbert D, Brochet E, Vahanian A. Mitral Regurgitation in Patients Referred for Transcatheter Aortic Valve Implantation Using the Edwards Sapien Prosthesis: Mechanisms and Early Postprocedural Changes. J Am Soc Echocardiogr. 2011 Nov 7 [Epub ahead of print].
33. Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol. 2011; 15: doi: 10.1038/nrcardio.2011.164 [Epub ahead of print].
34. Gurvitch R, Webb JG, Yuan R, Johnson M, Hague C, Willson AB, Toggweiler S, Wood DA, Ye J, Moss R, Thompson CR, Achenbach S, Min JK, Labounty TM, Cury R, Leipsic J. Aortic annulus diameter determination by multidetector computed tomography reproducibility, applicability, and implications for transcatheter aortic valve implantation. JACC Cardiovasc Inter. 2011;4: 1235-45.
35. Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino P, Thomas M. The SOURCE Registry: What is the learning curve in transapical aortic valve implantation. Eur J Cardiothorac Surg. 2011;39:853-860.
36. Lange R, Bleiziffer S, Piazza N, Mazzitelli D, Hutter A, Tassani-Prell P, Laborde JC, Bauernschmitt R. Incidence and treat ment of procedural cardiovascular complications associated with transarterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg. 2011;40: 1105-13.
37. Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017. July 2011. http://www.globaldata.com/reportstore/ Report.aspx?ID=Prosthetic-Heart-Valves-Global-Pipeline-Analysis-Competitive- Landscape-and-Market-Forecasts-to-2017&ReportType=Industry-Report
38. Webb JG, Wood DA, Gurvitch R, Cheung A, Ye J, Masson JB, Wendler O, Wijesinghe N. Transcatheter Valve-in-Valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121: 1848-57.
39. Chiam PT, Ruiz CE. Percutaneous transcatheter mitral valve repair: a classification of the technology. JACC Cardiovasc Interv. 2011;4:1-13.
40. Hekimian G, Detaint D, Messika-Zeitoun D, Attias D, Iung B, Himbert D, Brochet E, Vahanian A. Mitral Regurgitation in Patients Referred for Transcatheter Aortic Valve Implantation Using the Edwards Sapien Prosthesis: Mechanisms and Early Postprocedural Changes. J Am Soc Echocardiogr. 2012;25:160-05.
41. Tzikas A, Piazza N, van Dalen BM, Schultz C, Geleijnse ML, van Geuns RJ, Galema TW, Nuis RJ, Otten A, Gutierrez-Chico JL, Serruys PW, de Jaegere PP. Changes in mitral regurgitation after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;75:43-9.
42. Durst R, Avelar E, McCarty D, Poh KK, Friera LF, Llano MF, Chu J, Anumandla AK, Rodriguez LL, Mack MJ, Hanzel G, Kodali SK, Hung J, Picard MH. Outcome and improvement predictors of mitral regurgitation after transcatheter aortic valve implantation. J Heart Valve Dis. 2011;20:272-81.
43. Reynolds MR. Results of the PARTNER Trial Cohort: A Cost Effectiveness Analysis. Trans Catheter Therapeutics, San Francisco, 2011.
44. Franco A, Gerli C, Ruggeri L, Monaco F. Anaesthetic management of transcatheter aortic valve implantation. Ann Card Anaesth. 2012;15:54-63.
45. Hammerstingl C, Nickenig G, Grube E. Treatment of a degenerative stenosed CoreValve aortic bioprosthesis by transcatheter valve-in-valve insertion. Catheter Cardiovasc Interv. 2011 Jul.
46. McGrath PD, Wennberg DE, Dickens JD Jr, Siewers AE, Lucas FL, Malenka DJ, Kellett MA Jr, Ryan TJ Jr. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA. 2000;284:3139-44. (Pubitemid 32039076)
47. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, MaisanoF, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after trans-catheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
48. van der Boon RM, Nuis RJ, Van Mieghem NM, Benitez LM, van Geuns RJ, Galema TW, van Domburg RT, Geleijnse ML, Dager A, de Jaegere PP. Clinical outcome following transcatheter aortic valve implantation in patients with impaired left ventricular systolic function. Catheter Cardiovasc Interv. 2011 Nov 25.
49. Daneault B, Kirtane AJ, Kodali SK, Williams MR, Genereux P, Reiss GR, Smith CR, Moses JW, Leon MB. Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. J Am Coll Cardiol. 2011;58:2143-50.
50. Erkapic D, DE Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH. Risk for Permanent Pacemaker After Transcatheter Aortic Valve Implantation: A Comprehensive Analysis of the Literature. J Cardiovasc Electrophysiol. 2011 Nov.
51. Tissot CM, Attias D, Himbert D, Ducrocq G, Iung B, Dilly MP, Juliard JM, Lepage L, Détaint D, Messika-Zeitoun D, Nataf P, Vahanian A. Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. EuroIntervention. 2011;7:49-56.
52. Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Büllesfeld L, Khattab AA, Huber C, Eberle B, Erdös G, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011;161:1114-24.
53. Dehédin B, Guinot PG, Ibrahim H, Allou N, Provenchère S, Dilly MP, Vahanian A, Himbert D, Brochet E, Radu C, Nataf P, Montravers P, Longrois D, Depoix JP. Anesthesia and Perioperative Management of Patients Who Undergo Transfemoral Transcatheter Aortic Valve Implantation: An Observational Study of General Versus Local/Regional Anesthesia in 125 Consecutive Patients. J Cardiothorac Vasc Anesth. 2011;25:1063-43.
54. Conradi L, Seiffert M, Treede H, Silaschi M, Baldus S, Schirmer J, Kersten JF, Meinertz T, Reichenspurner H. Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk. J Thorac Cardiovasc Surg. 2012;143:64-71.
55. Eggebrecht H, Schäfer U, Treede H, Boekstegers P, Babin-Ebell J, Ferrari M, Möllmann H, Baumgartner H, Carrel T, Kahlert P, Lange P, Walther T, Erbel R, Mehta RH, Thielmann M. Valve-in-Valve Transcatheter Aortic Valve Implantation for Degenerated Bioprosthetic Heart Valves. JACC Cardiovasc Interv. 2011;4:1218-27.
56. Gurvitch R, Cheung A, Ye J, Wood DA, Willson AB, Toggweiler S, Binder R, Webb JG. Transcatheter Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves. J Am Coll Cardiol. 2011;58:2196-209.
57. Piazza N, Bleiziffer S, Brockmann G, Hendrick R, Deutsch MA, Opitz A, Mazzitelli D, Tassani-Prell P, Schreiber C, Lange R. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 2). JACC Cardiovasc Interv. 2011;4:733-42.
58. Piazza N, Bleiziffer S, Brockmann G, Hendrick R, Deutsch MA, Opitz A, Mazzitelli D, Tassani-Prell P, Schreiber C, Lange R. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 1). JACC Cardiovasc Interv. 2011;4:721-32.
59. Iung B. Management of the elderly patient with aortic stenosis. Heart. 2008;94:519-524. (Pubitemid 351441416)
60. Otto CM, Verrier ED. Mitral regurgitation -what is best for my patient? N Engl J Med. 2011;364:1462-1463.
61. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J. 2011;32:140-147.
62. Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P, Palmer S, Busca R, Sculpher M. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2011. Nov 25. [Epub ahead of print]